Neuphoria Therapeutics, Inc. (NEUP)
4.715
-0.18
(-3.58%)
USD |
NASDAQ |
Jun 03, 16:00
4.715
0.00 (0.00%)
After-Hours: 19:59
Neuphoria Therapeutics Total Assets (Quarterly) : 34.81M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 186.46M |
| Amgen, Inc. | 92.50B |
| Anika Therapeutics, Inc. | 179.39M |
| BioCryst Pharmaceuticals, Inc. | 465.05M |
| Imunon, Inc. | 8.019M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.385M |
| Shareholders Equity (Quarterly) | 29.42M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 14.31 |
| Net Debt Paydown Yield | 0.20% |